| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |